<DOC>
	<DOC>NCT02880384</DOC>
	<brief_summary>Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using current diagnostic tests to the number detected using the BioFire Diagnostics investigational polymerase chain reaction (PCR) platform.</brief_summary>
	<brief_title>Pathogen Detection and Community Acquired Pneumonia</brief_title>
	<detailed_description>Patients diagnosed in the emergency department with CAP that requires hospitalization provide a sputum sample for culture and sensitivity testing, urine for detection of S. pneumonia and L. pneumophila, an anterior nasal swab for S. aureus PCR, a nasopharyngeal swab for S. pneumonia PCR and the FilmArray LRTI v.2.0 IUO Panel, and blood for procalcitonin testing and, in cases in which the patient is suffering rigors and hypotension, cultures. As part of this study, sputum or sputum equivalent will be acquired for testing using the FilmArray LRTI v.2.0 IUO Panel.</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<criteria>Emergency Department physician diagnosis of CAP requiring hospitalization Inability to obtain sputum or sputum equivalent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>